Urological cancer, Malmö
331 – 340 of 554
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Cabozantinib Resolves Bone Scans in Tumor-Naive Mice Harboring Skeletal Injuries
- Contribution to journal › Article
-
Mark
The Clinical Impact of Genetic Susceptibility to Prostate Cancer.
- Contribution to journal › Debate/Note/Editorial
-
Mark
(18)F-fluorocholine PET/CT compared with extended pelvic lymph node dissection in high-risk prostate cancer.
- Contribution to journal › Article
-
Mark
Non-invasive mapping of deep-tissue lymph nodes in live animals using a multimodal PET/MRI nanoparticle.
- Contribution to journal › Article
-
Mark
Bone Scan Index as a prognostic imaging biomarker during androgen deprivation therapy.
- Contribution to journal › Article
-
Mark
Androgen receptor polymorphism dependent variation in prostate specific antigen concentrations of European men.
- Contribution to journal › Article
-
Mark
Identification of plasma protein profiles associated with risk groups of prostate cancer patients.
- Contribution to journal › Article
-
Mark
Cancer-associated Changes in the Expression of TMPRSS2-ERG, PCA3, and SPINK1 in Histologically Benign Tissue From Cancerous vs Noncancerous Prostatectomy Specimens.
- Contribution to journal › Article
-
Mark
REST mediates androgen receptor actions on gene repression and predicts early recurrence of prostate cancer.
- Contribution to journal › Article
-
Mark
TCF7L2 type 2 diabetes risk variant, lifestyle factors, and incidence of prostate cancer.
- Contribution to journal › Article
